Oracle Investment Management Inc Biohaven Pharmaceutical Holding CO Ltd. Put Options Transaction History

Oracle Investment Management Inc

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $25.1 Million - $32.6 Million	-228,200 Reduced 91.94%	20,000 $212,000
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $14.1 Million - $22.5 Million	214,600 Added 638.69%	248,200 $1.82 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $5.95 Million - $8.51 Million	-92,800 Reduced 73.42%	33,600 $17,000
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $4.72 Million - $6.25 Million	126,400 New	126,400 $1.81 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oracle Investment Management Inc with notifications on news.